Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Inari Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that inflated the company's stock price during the specified class period [1][5]. Group 1: Class Action Details - The class period for the lawsuit is from February 23, 2022, to February 28, 2024, with a deadline for registration set for July 12, 2024 [3][6]. - Shareholders who purchased shares of Inari Medical during this period are encouraged to register for the class action and may be eligible for recovery [4][6]. Group 2: Allegations Against Inari Medical - The complaint alleges that the defendants made materially false and/or misleading statements and failed to disclose critical information, leading to an artificial inflation of Inari's stock price [5]. - It is claimed that these actions caused shareholders to purchase Inari common stock at prices that did not reflect its true value [5]. Group 3: Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [6]. - There is no cost or obligation for shareholders to participate in the class action [6].
Class Action Filed Against Inari Medical, Inc. (NARI) - July 12, 2024 Deadline to Join – Contact The Gross Law Firm